News

As per the terms of the agreement, ProMetic will be responsible to accelerate an affinity resin product and associated manufacturing process conditions for its client. The agreement will

Dificid tablets are indicated for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age or older. The FDA approval was given on the basis

The high dose cohort (3 mg/kg/dose) Phase II trial expects to recruit around 21 patients in the trial. The company anticipates to release the top line results of

Paras Pharmaceuticals’ personal care business includes brands such as Recova, Setwet, Zatak, Borosoft, Livon, Moov, Krack, ItchGuard, RingGuard and Dermicool etc. RB, which is keen to focus on

The lawsuit seeks to stop Vi-Jon from violating P&G’s intellectual property and selling the infringing products. The lawsuit alleges that Vi-Jon is violating P&G’s intellectual property by manufacturing

SPRIX, which uses an Aptar Pharma nasal spray pump, is a non-invasive treatment for pain management. Aptar Pharma worked closely with Roxro Pharma for over 7 years to

Krystexxa is indicated as a treatment for chronic gout in adult patients refractory to conventional therapy. The MAA was submitted on the basis of safety and efficacy data

TheraPEG technology is used for the site-specific attachment of polyethylene glycol (PEG) polymer to therapeutic proteins. TheraPEG offers site-specific conjugation to disulfide bonds to achieve better product homogeneity

Following the acquisition, Aegera’s 20 plus employees will be joining Pharmascience’s team. The acquisition will allow Pharmascience to enhance its research and development activities through the continuance of